insights_auto
Kwa nini ALTME imeongezeka kwa 8.15%?
Fahamu zaidichevron_right
ALTME:EPA
TME Pharma NV
€ 0.12
arrow_upward
+8.15%(+0.0090) Siku 1
23 Okt, 10:53:09 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALTME...
Fungua
€ 0.11
Juu
€ 0.12
Chini
€ 0.11
Mtaji wa soko
11.84M
Wastani wa kiasi cha mauzo
1.50M
Kiasi cha mauzo ya hisa
elfu 422.34
Juu kwa wiki 52
€ 0.17
Chini kwa wiki 52
€ 0.05
EPS
-€ 0.03
Idadi ya wafanyakazi
0
Fungua
€ 0.11
Juu
€ 0.12
Chini
€ 0.11
Mtaji wa soko
11.84M
Wastani wa kiasi cha mauzo
1.50M
Kiasi cha mauzo ya hisa
elfu 422.34
Juu kwa wiki 52
€ 0.17
Chini kwa wiki 52
€ 0.05
EPS
-€ 0.03
Idadi ya wafanyakazi
0
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
StreetInsider
·
dakika 9 zilizopita
WeShop Opens Share Claims for UK Members on November 23, Marking One Year on Nasdaq
Yahoo Finance
·
dakika 49 zilizopita
The S&P 500 May Depend on the Fortunes of These 3 Companies Right Now. Here’s the Good News and the Bad News for Investors.
WSJ
·
dakika 27 zilizopita
Nasdaq Futures Steady as AI Selloff Pauses
The Motley Fool
·
dakika 50 zilizopita
This Dividend King Yielding 3X the S&P 500 Looks Like a Buy Right Now.
Wasifu
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Kuhusu TME Pharma NV
Afisa Mkuu Mtendaji (CEO)Aram Mangasarian
Wafanyakazi0
Lilianzishwa1997
Makao makuu-
Sekta-
Tovutitmepharma.com